[Federal Register Volume 79, Number 81 (Monday, April 28, 2014)]
[Notices]
[Pages 23376-23377]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-09556]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-390]


Controlled Substances: 2014 Established Aggregate Production 
Quotas for Four Temporarily Controlled Synthetic Cannabinoids

AGENCY: Drug Enforcement Administration (DEA), Department of Justice.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice establishes the initial 2014 aggregate production 
quotas for four temporarily controlled synthetic cannabinoids: N-(1-
amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide 
(ADB-PINACA); N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-
1H-indazole-3-carboxamide (AB-FUBINACA);

[[Page 23377]]

quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-
22; 5F-PB-22); and quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB-
22; QUPIC).

DATES: Effective April 28, 2014.

FOR FURTHER INFORMATION CONTACT: Ruth A. Carter, Office of Diversion 
Control, Drug Enforcement Administration; Mailing Address: 8701 
Morrissette Drive, Springfield, Virginia 22152, Telephone: (202) 598-
6812.

SUPPLEMENTARY INFORMATION:

Background

    Section 306 of the Controlled Substances Act (CSA) (21 U.S.C. 826) 
requires the Attorney General to establish aggregate production quotas 
for each basic class of controlled substance listed in schedules I and 
II and for the list I chemicals ephedrine, pseudoephedrine, and 
phenylpropanolamine. The Attorney General has delegated this authority 
to the Administrator of the DEA, 28 CFR 0.100, who in turn has 
redelegated that authority to the Deputy Administrator of the DEA, 28 
CFR part 0, subpt. R, App.
    On February 10, 2014, the DEA published in the Federal Register a 
final order to temporarily place four synthetic cannabinoids, quinolin-
8-yl 1-pentyl-1H-indole-3-carboxylate (PB-22), quinolin-8-yl 1-(5-
fluoropentyl)-1H-indole-3-carboxylate (5F-PB-22), N-(1-amino-3-methyl-
1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-
FUBINACA), and N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-
indazole-3-carboxamide (ADB-PINACA), into schedule I of the CSA (79 FR 
7577), making all regulations pertaining to schedule I controlled 
substances applicable to the manufacture of PB-22, 5F-PB-22, AB-
FUBINACA, and ADB-PINACA, including the requirement to obtain a 
manufacturing quota pursuant to 21 CFR part 1303.
    The 2014 aggregate production quotas for PB-22, 5F-PB-22, AB-
FUBINACA, and ADB-PINACA represent those quantities that may be 
manufactured in the United States in 2014 to provide for the estimated 
scientific, research, and industrial needs of the United States, lawful 
export requirements, and the establishment and maintenance of reserve 
stocks.
    On March 7, 2014, the DEA published a notice titled, ``Controlled 
Substances: 2014 Proposed Aggregate Production Quota for Four 
Temporarily Controlled Synthetic Cannabinoids'' in the Federal Register 
(79 FR 13076). That notice proposed the 2014 aggregate production 
quotas for PB-22, 5F-PB-22, AB-FUBINACA, and ADB-PINACA. Interested 
persons were invited to comment on or object to the proposed aggregate 
production quotas for PB-22, 5F-PB-22, AB-FUBINACA, and ADB-PINACA on 
or before April 7, 2014. No comments were received.

Analysis for 2014 Established Aggregate Production Quotas

    In determining the 2014 aggregate production quotas for quinolin-8-
yl 1-pentyl-1H-indole-3-carboxylate (PB-22), quinolin-8-yl 1-(5-
fluoropentyl)-1H-indole-3-carboxylate (5F-PB-22), N-(1-amino-3-methyl-
1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-
FUBINACA), and N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-
indazole-3-carboxamide (ADB-PINACA), the DEA has taken into 
consideration the factors set forth at 21 CFR 1303.11, pursuant to 21 
U.S.C. 826(a), and other relevant factors, including 2014 export 
requirements, industrial use, applications for quotas, as well as 
information on research and product development requirements.
    Pursuant to 21 U.S.C. 826 and in accordance with 21 CFR 1303.11, 
the Deputy Administrator hereby establishes the 2014 aggregate 
production quotas for the PB-22, 5F-PB-22, AB-FUBINACA, and ADB-PINACA, 
expressed in grams of anhydrous acid or base, as follows:

------------------------------------------------------------------------
                                                            Established
                 Basic class--schedule I                    2014 Quota
------------------------------------------------------------------------
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-               15 g
 indazole-3-carboxamide (ADB-PINACA)....................
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-            15 g
 1H-indazole-3-carboxamide (AB-FUBINACA)................
quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate            15 g
 (5-fluoro-PB-22; 5F-PB-22).............................
quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB-22;              15 g
 QUPIC).................................................
------------------------------------------------------------------------

    In accordance with 21 CFR 1303.13, upon consideration of the 
relevant factors, the Deputy Administrator may adjust the 2014 
aggregate production quotas for PB-22, 5F-PB-22, AB-FUBINACA, and ADB-
PINACA as needed.

    Dated: April 21, 2014.
Thomas M. Harrigan,
Deputy Administrator.
[FR Doc. 2014-09556 Filed 4-25-14; 8:45 am]
BILLING CODE 4410-09-P